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CCT complex restricts neuropathogenic
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Aberrant protein aggregation is controlled by various chaperones, including CCT (chaperonin
containing TCP-1)/TCP-1/TRiC. Mutated CCT4/5 subunits cause sensory neuropathy and
CCT5 expression is decreased in Alzheimer’s disease. Here, we show that CCT integrity is
essential for autophagosome degradation in cells or Drosophila and this phenomenon is
orchestrated by the actin cytoskeleton. When autophagic ﬂux is reduced by compromise of
individual CCT subunits, various disease-relevant autophagy substrates accumulate and
aggregate. The aggregation of proteins like mutant huntingtin, ATXN3 or p62 after CCT2/5/7
depletion is predominantly autophagy dependent, and does not further increase with CCT
knockdown in autophagy-defective cells/organisms, implying surprisingly that the effect of
loss-of-CCTactivity on mutant ATXN3 or huntingtin oligomerization/aggregation is primarily
a consequence of autophagy inhibition rather than loss of physiological anti-aggregation
activity for these proteins. Thus, our ﬁndings reveal an essential partnership between two key
components of the proteostasis network and implicate autophagy defects in diseases with
compromised CCT complex activity.
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I
ntracellular protein misfolding and aggregation are seen in
many late-onset neurodegenerative diseases, called proteino-
pathies, such as Alzheimer’s disease, Parkinson’s disease,
tauopathies, and the nine polyglutamine expansion diseases,
exempliﬁed by Huntington’s disease. In the autosomal dominant
forms of these conditions, most of the mutations confer novel
toxic functions on the speciﬁc protein. Thus, the phenotypic
severity in model systems frequently correlates with the levels of
the relevant proteins1. The accumulation and aggregation of such
proteins is buffered by the proteostasis network that regulates
either the concentrations or folding of intracellular clients. The
concentration of such intracytoplasmic clients is regulated in part
by degradation pathways, including the ubiquitin–proteasome
pathway and (macro)autophagy. Autophagy is a lysosomal
degradation pathway where damaged cellular material and
long-lived proteins are engulfed into double-membraned
structures named autophagosomes, which ultimately fuse with
lysosomes where their contents are degraded. Since mutant
huntingtin, p62, tau and many other intracytoplasmic
neurodegenerative disease-associated aggregate-prone proteins
are autophagy substrates, the levels of these proteins increase in
both the soluble and aggregated states when autophagy is
compromised1–3.
Protein folding is assisted by the chaperone machinery.
Here, one key player is chaperonin containing TCP-1 (CCT,
also known as TRiC or group II chaperonin), a cytosolic
ATP-dependent eukaryotic chaperonin comprising two rings of
eight different but related subunits, each thought to be
represented once per eight-membered ring. Autosomal recessive
mutations of the CCT5 and CCT4 subunits lead to loss-of
function phenotypes that manifest with a devastating sensory
neuropathy4,5. Moreover, recent studies suggested that mRNA
levels of the TRiC complex are repressed in Alzheimer’s disease
patient brain samples6. This might be important, as tau,
which accumulates in Alzheimer’s disease, is a client protein of
many chaperones and co-chaperones (Hsp90/CHIP and Hsp70
complexes), including CCT, that together control both its
stabilization and degradation7. Therefore it is important to
understand the mechanistic consequences of impaired CCT
activity in neurodegenerative diseases. TRiC was initially
thought to fold only the cytoskeletal proteins actin and tubulin
but is now known to handle a wide range of cytoplasmic
clients8,9.
A role for CCT as a folding enhancer has been suggested by
studies showing that it can prevent mutant huntingtin (htt)
aggregation by direct binding to the aggregate-prone N-terminal
of htt in vitro10–12. Recent studies also showed that the apical
domain of CCT1 subunit is able to decrease the formation of
visible inclusions and oligomeric mutant htt-exon1 fragment
species independently of the TRIC complex per se13. A recent
study observed that both CCT3 and the apical domain of CCT1
(ApiCCT1) reduced htt levels in cortical neurons from an
Huntington’s disease mouse model, which was associated with
normalized anterograde BDNF transport, restored retrograde
BDNF transport and normalized lysosomal transport14.
Accordingly, we and others anticipated that the main role of
this chaperone was to directly regulate the aggregation of
huntingtin and related substrates. While this direct binding/
sequestration mechanism represents an intuitive mechanism for
CCT to regulate mutant huntingtin aggregation, indirect
mechanisms dependent on degradation pathways have not been
tested, or excluded previously. Here we report our unexpected
ﬁndings that loss of CCT function increases the accumulation of
well characterized aggregate-prone proteins, like the N-terminal
mutant htt fragment, mainly as a consequence of autophagy
inhibition.
Results
CCT is required for autophagosome degradation. To test if the
chaperonin complex played a role in autophagy, we designed
either siRNA knockdown or lentiviral shRNA transduction
experiments targeting individual subunits of the complex
(CCT2/5/7)—all eight subunits are required for the proper
function of the chaperonin complex and depletion of any of them
will reduce its activity10. As this is a complex, knockdown of one
subunit may impact the levels of other components—(indeed, we
observed that CCT2 knockdown also reduces CCT7 subunit
levels, see Supplementary Figs 1a and 13 for full scans of blots in
the paper). Autophagy was quantiﬁed by measuring the levels
of LC3-II, a classical marker of autophagosome abundance15.
LC3-II levels on western blots might vary between control and
treatment conditions as a result of changes in the formation
and/or degradation of autophagosomes16,17. To distinguish
between these two possibilities, we exposed the cells to
saturating concentrations of the lysosomal V-ATP-ase inhibitor
Baﬁlomycin A1 (BafA1), which blocks LC3-II/ autophagosome
degradation18,19 and reveals changes in autophagosome synthesis.
Depletion of individual CCT subunits in HeLa cells or mouse
primary cortical neurons (depletion efﬁciency in Supplementary
Fig. 1a,b) increased the steady state levels of LC3-II in the absence
of Baﬁlomycin A1. In the presence of Baﬁlomycin A, these
knockdowns resulted in a modest consistent LC3-II decrease in
HeLa cells (Fig. 1a,b; Supplementary Fig. 1c) and neurons (when
we compare the targeting to scramble shRNAs; Fig. 1c,d). The
large increase in autophagosome number and modest decrease in
autophagosome formation (LC3-II in the presence of BafA1)
suggest that depletion of individual CCT subunits primarily
impairs degradation of autophagosomes in both cell types,
and this also appears to be associated with a modest decrease
in autophagosome biogenesis. We conﬁrmed the block in
autophagosome degradation with another assay based
on measuring the autophagy ﬂux in HeLa cells and primary
cortical neurons of mice transgenically expressing the tandem
tagged mRFP-GFP-LC3 reporter20,21 (Supplementary Fig. 1d).
This assay allows one to characterize the LC3-II vesicles
and discriminate between autophagosomes or non-acidiﬁed
lysosomes, and acidiﬁed autolysosomes. Due to the different
pKa of the two LC3 tags (o4.5 for mRFP and around 6 for GFP),
the GFP signal is rapidly quenched by the acidic lysosomal
environment, while the mRFP persists20,21. Thus, the vesicles
that emit both red and green signals are autophagosomes or
non-acidiﬁed lysosomes, while the vesicles that emit only the red
signal (due to the GFP-signal being quenched by an acidic
environment) are acidic autolysosomes. Knockdowns of CCT
complex subunits (CCT2/5/7) increased the number and size of
autophagosomes/non-acidiﬁed lysosomes (yellow vesicles/GFP
dots), while the number of acidic autolysosomes (red only
vesicles/mRFP only dots) was signiﬁcantly decreased (Fig. 1e,f;
Supplementary Fig. 1e,f). These data were consistent with our
previous western blot based results showing a block in LC3-II
degradation/reduced autophagy ﬂux. For these experiments,
BafA1 was used as a positive control for impaired
autophagosome ﬂux/degradation.
CCT regulates lysosomal functioning. The previous results
showing a block in autophagosome degradation under CCT
depletion conditions may be due to decreased lysosomal activity/
degradation (reduced autophagosome degradation), impaired
autophagosome maturation with reduced autophagosome-
lysosome fusion, or both. To clarify which of these situations
caused the block in autophagosome degradation in CCT-depleted
cells, we tested each hypothesis (impaired autophagosome-
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Figure 1 | CCT knockdown reduces LC3 turnover and autophagosome formation. (a) LC3-II levels in HeLa cells transfected with siRNA against scrambled
control or CCT subunits treated with vehicle (DMSO) or Baﬁlomycin A1 (400nM) for 5 h. GAPDH is loading control. (b) LC3-II/GAPDH densitometry
from a. Graphs show means±s.d. of triplicate samples in the absence or presence of Baﬁlomycin A1. Similar results were observed in at least three
independent experiments. (n¼ 3; **Po0.01, *Po0.05; two-tailed one sample t-test). For combined data of independent biological replicates, see
Supplementary Fig. 1c. (c) LC3-II levels in mouse primary cortical neurons transduced with two different shRNA lentiviral particles targeting either control
(Ctrl sh#1 is empty vector and Ctrl sh#2 is control scramble) or the mouse Cct5 (Cct5 sh#1 and Cct5 sh#2). Cells were treated with vehicle (DMSO) or
Baﬁlomycin A1 at 200nM for 12 h. GAPDH is loading control. (d) LC3-II/GAPDH densitometry from c. Graphs show mean±s.d. of triplicate samples in the
absence or presence of Baﬁlomycin A1. Similar results were observed in another two independent experiments. In Baﬁlomycin A1 conditions, the Cct5
shRNAs (#1 or #2) treated cells showed signiﬁcant reduced LC3-II levels when compared with the scramble control (Ctrl sh#2) treated neurons (n¼ 3;
*Po0.05, NS, not signiﬁcant; two-tailed t-test), but not-signiﬁcant if compared with the empty-vector control (Ctrl sh#1) condition (n¼ 3; NS, not
signiﬁcant; two-tailed one sample t-test). (e) GFP dot numbers (autophagosomes/non-acidiﬁed autolysosomes, mRFP-GFP double labelled vesicles) and
mRFP-only dots (acidiﬁed autolysosomes) in HeLa cells. HeLa cells stably expressing mRFP-GFP-LC3 were treated as in a then seeded in a 96-well plate
and subjected to automated Cellomics visualization and analysis. Graph shows results from one representative experiment. We analysed 100–200 cells per
well (from a 96-well plate) with 10–12 wells per condition. Similar data were seen in other two independent experiments. Bars—means±s.e.m.
(***Po0.001; two-tailed t-test). (f) Representative confocal z-stack images (left panel) and total number of GFP dots (autophagosomes) and mRFP-only
dots (autolysosomes)—left panel, in mouse primary cortical neurons from mRFP-GFP-LC3 transgenic mice. Cortical neurons were plated in live cell dishes,
treated as in d and the numbers of dots were manually counted after confocal microscopy. Graph shows data from three independent biological replicates;
100–150 neurons counted per each condition. Bars—means±s.e.m. (***Po0.001; two-tailed t-test). Scale bar—10 mm.
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lysosome fusion or decreased lysosomal acidiﬁcation) by
performing appropriate assays.
To assess autophagosome-lysosome fusion in control or
CCT-depleted cells, we initially quantiﬁed and characterized
LC3 (autophagosome marker) and LAMP1/CD63 (lysosome/late
endosome markers) double-labelled vesicles. Knockdown of
individual chaperonin subunits (CCT2/5/7) increased the
colocalization of endogenous LC3 with LAMP1, suggesting that
autophagosome-lysosome fusion was not impaired in HeLa
cells (Fig. 2a,b; Supplementary Fig. 2a,b) and the same
phenomenon was seen when we knocked down Cct5 in primary
mouse cortical neurons (Supplementary Fig. 2c,d). This was not
an artefact due to increased autophagosome size/number or
clustering, as the same phenomenon (increased LC3/LAMP1
colocalization compared with control) was seen after we brieﬂy
exposed cells to the microtubule-depolymerizing drug nocodazole
which disperses lysosomes uniformly in the cell and dissociates
them from the non-fused autophagosomes found in their close
proximity22 (Fig. 2a; Supplementary Fig. 2a–b). Indeed,
nocodazole treatment signiﬁcantly reduced LC3-LAMP1
colocalization by at least 20–30% in control cells (as previously
reported22), but had no such effect in CCT2/5/7 knockdown cells,
when compared with cells without nocodazole (Fig. 2a;
Supplementary Fig. 2a,b). These data were reinforced by double
immunostaining for endogenous p62 (an autophagic cargo)
and CD63 (another late endosome/lysosome marker) in
ordinary HeLa cells or HeLa cells stably expressing GFP-LC3
exposed to CCT5 siRNAs. The colocalizations of endogenous
p62/CD63 (Supplementary Fig. 3), GFP-LC3/endogenous
CD63 (Supplementary Fig. 4) and endogenous p62/GFP-LC3
(Supplementary Fig. 4) were increased upon CCT5 knockdown
compared with control cells. Note that Baﬁlomycin A1, used as a
control in these experiments, likely affects both autophagosome–
lysosome fusion as well as autophagosome degradation23.
To understand the functionality of the lysosomes, we initially
observed that CCT depletion caused the enlargement of
LAMP1/CD63-positive compartments and their redistribution
from a preferentially perinuclear localization in control cells to a
scattered phenotype in CCT-deﬁcient cells, phenomena com-
monly associated with compromised lysosomal function (Fig. 2a;
Supplementary Figs 2a,3a,4a). At this point, it is important to
mention that many LAMP1-positive vesicles may be amphisomes
or autophagosome-nonacidic autolysosome fusions, as LAMP1/
CD63 showed signiﬁcantly increased colocalization with LC3, in
CCT2/5/7 knockdown HeLa cells or Cct5-depleted primary
cortical neurons, or with p62, in CCT5 knockdown HeLa cells
(Fig. 2a; Supplementary Figs 2–4). Lysosomal function relies on
the capacity of lysosomal hydrolytic enzymes to become activated
in an acidic environment of about pH 4.5. Indeed, the maturation
and in vitro activity of the lysosomal protease cathepsin L (CTSL)
was decreased by depletion of individual CCT subunits in HeLa
(Fig. 2b,c; Supplementary Fig. 5a,b) and mouse primary cortical
neurons (Supplementary Fig. 5c,d). Reduced maturation of
cathepsins can result from intracellular mistrafﬁcking and/or
increased lysosomal pH (for example, see effects with BafA1
in Supplementary Fig. 5)24. Consistent with intracellular
mistrafﬁcking of lysosomal enzymes, we observed increased
reticular staining for cathepsin D (CTSD) and less localization in
the lysosomal compartment in CCT-depleted cells (Fig. 2d;
Supplementary Fig. 6a,b). This was associated with increased
colocalization between cathepsin D and calnexin, an ER marker
(Fig. 2d; Supplementary Fig. 6c–e), indicating mistrafﬁcking of
lysosomal enzymes and their sequestration in the ER. We next
measured lysosomal pH with the ratiometric- and pH-sensitive
probe LysoSensor Yellow/Blue by live-cell imaging. The
LysoSensor Yellow/Blue provides the advantage of simultaneous
dual-emission, predominantly yellow ﬂuorescence in an acidic
environment and blue in neutral and less-acidic vesicles. The
information provided by this probe is based on the ratio of yellow
to blue intensity and therefore is independent of potential
differences in probe uptake between treated and control cells.
CCT subunit knockdowns elevated the lysosomal pH in HeLa
cells (Fig. 2e) with a more dramatic phenotype in primary cortical
neurons, where Cct5 was depleted by lentiviral transduction
(reduced yellow/blue ratio, BafA1 was used as a positive control)
(Fig. 2f; Supplementary Fig. 6f). The enhanced lysosomal pH
(here observed in CCT-depleted cells) also correlates with the
enlargement and redistribution of lysosomes towards cell
periphery25,26. This pH disturbance is likely due to reduced
delivery of the Voa1 (a subunit of the V-ATPase proton pump) to
lysosomes, which indeed showed less localization in the LAMP1
compartment in Cct5-depleted primary mouse cortical neurons
(Fig. 2g; Supplementary Fig. 6g). These data (reduced lysosomal
acidiﬁcation and uncompromised autophagosome–lysosome
fusion) are consistent with previous observations that
V-ATPase defects affect only autophagosome degradation
per se and not their fusion with lysosomes27. Additionally,
this phenotype of non-acidiﬁed lysosomes associated with
apparently normal autophagosome–lysosome fusion is seen in
ATP13A2 deﬁciency28. These results suggest that the
autophagosome degradation impairment seen in CCT-depleted
cells is a direct consequence of reduced lysosomal acidiﬁcation
which is likely due to impaired V-ATPase trafﬁcking.
Actin is one of the major clients for CCT folding29,30 and, as
expected, we observed that CCT knockdown disrupted the
F-actin cytoskeleton (Supplementary Fig. 7a). Since actin
depolymerization blocks autophagosome degradation31,32, we
hypothesized that actin disruption mediated the lysosomal
phenotypes caused by CCT depletion. If actin defects were
responsible for the autophagy–lysosomal impairment seen in
CCT-depleted conditions, then one would expect actin
depolymerization to mirror the lysosomal dysfunction caused
by CCT loss-of-function. Indeed, actin depolymerizing drugs
(latrunculin A and cytochalasin D) impaired autophagosome
clearance (Fig. 3a–c; Supplementary Fig. 7b–d), reduced
cathepsin L maturation and activity (Fig. 3d; Supplementary
Fig. 7e,f), decreased the amounts of cathepsin D in the lysosomal
compartment (Fig. 3e; Supplementary Fig. 7g) with increased
cathepsin D–calnexin colocalization (Fig. 3f; Supplementary
Fig. 7h) and elevated lysosomal pH (Fig. 3g), all phenotypes
seen with CCT subunit depletion. We next investigated
autophagosome–lysosome fusion in cells transiently expressing
both mRFP-LC3 (autophagosomes) and lgp120-GFP (LAMP1,
lysosomes and late endosomes) exposed to short-term latrunculin
A treatment. As predicted, autophagosome–lysosome fusion was
not compromised under these circumstances (Fig. 3h–j).
As these data show that actin depolymerization mirrors the
lysosomal and autophagy defects seen in CCT-depleted cells,
perturbations in the actin cytoskeleton dynamics may be
mechanistically sufﬁcient to explain the block in autophagosome
degradation caused by CCT loss-of-function. Indeed, knockdown
of individual CCT subunits in cells exposed to latrunculin A,
further supported the importance of actin dysfunction as a
mediator of the CCT-deﬁciency autophagy–lysosome phenotype,
as latrunculin A failed to further increase basal LC3-II
levels (Fig. 4a,b) or reduce cathepsin L activity (Fig. 4c,d) in
CCT5-depleted cells. To reinforce the role of actin cytoskeleton in
CCT-mediated autophagy, we next investigated the role of
prefoldin (PFD) in the autophagy–lysosome pathway. Knock-
down of prefoldin (depletion of any of the prefoldin subunits is
enough to impair the PFD complex activity), the co-chaperone
that delivers actin and tubulin to the TRiC complex for their ﬁnal
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Figure 2 | CCT is required for lysosomal functioning and autophagosomes degradation. (a) LC3 (anti-mouse Alexa 488) and LAMP1 (anti-rabbit Alexa
568) colocalization in HeLa cells depleted for CCT5. Right panel: quantiﬁcation of colocalization (Pearson’s coefﬁcient). More than 30 cells were counted
per condition. Bars—means±s.e.m. (***Po0.001, *Po0.05, NS, not signiﬁcant; two-tailed t-test). Similar results were achieved in at least two
independent experiments. Scale bar, 10mm. (b) Immunoblot showing Cathepsin L (CTSL) maturation in CCT5 knockdown HeLa cells. Graph showing the
quantiﬁcation of mature/precursor CTSL ratio is on right as mean±s.d. (n¼ 3; **Po0.01, *Po0.05; two-tailed one sample t-test). (c) Cathepsin L activity
in HeLa cells depleted for CCT5. Fluorescence intensity was expressed as percentage of control. Bars—mean±s.d. (n¼ 3; **Po0.01; two-tailed t-test).
(d) Cathepsin D (CTSD, anti-mouse Alexa 488)—LAMP1 (anti-rabbit Alexa 568) and cathepsin D (anti-mouse Alexa 488) —calnexin (anti-rabbit Alexa
568) double-immunostaining in CCT5-knockdown cells. More than 40 cells were quantiﬁed per experiment (each experiment was performed at least twice
with similar results). Bars—mean of Pearson’s coefﬁcient±s.e.m. (***Po0.001; two-tailed t-test). Scale bar—10mm. See also Supplementary Fig. 6e.
(e) Lysosomal pH in CCT-depleted cells. The Lysosensor Yellow Blue intensity was measured in both yellow and blue channels. Intensities ratio is a
qualitative measure of lysosomal pH. Baﬁlomycin A1 (Baf A1) was used as a positive control (400nM, 3 h) for increased lysosomal pH 450 cells were
analysed per experiment, for each condition. Experiment was performed at least 3 times with similar results. Bars—mean±s.e.m. (***Po0.001; two-tailed
t-test). (f) Lysosomal pH in Cct5-depleted mouse primary cortical neurons. Lysosensor Yellow Blue intensity was measured as in e. Baﬁlomycin A1 was
used as a positive control (400nM, 6 h) for increased lysosomal pH 440 neurons were analysed per experiment and per condition. Experiment was
performed at least three times with similar results. Bars—means±s.e.m. (***Po0.001; two-tailed t-test). See also Supplementary Fig. 6f. (g) Voa1
(anti-rabbit Alexa555) and Lamp1 (anti-rat Alexa647) double-immunostaining in mouse primary cortical neurons. Neurons were plated and treated as in f.
More than 30 neurons were counted per condition. PC is Pearson’s coefﬁcient; M1 is Mander’s coefﬁcient 1, which indicates the Voa1 localization in the
Lamp1 compartment. Bars—means±s.e.m. (***Po0.001; two-tailed t-test). Scale bar—10mm. See also Supplementary Fig. 6g.
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Figure 3 | Depolymerization of actin cytoskeleton reduces the lysosomal biogenesis. (a) LC3-II levels in HeLa cells treated with latrunculin A (1 mM) or
cytochalasin D (1 mM) for 3 h in the presence or absence of Baﬁlomycin A1 (400nM, 3 h). (b) LC3-II/GAPDH densitometry in HeLa cells treated with
Latrunculin A or Cytochalasin D as in a. Bars—means±s.d. (n¼ 3; **Po0.01; *Po0.05; two-tailed one sample t-test). (c) GFP dot numbers
(autophagosomes) and mRFP-only dots (autolysosomes) in HeLa cells stably expressing mRFP-GFP-LC3 and independently treated with 1 mM latrunculin A
or cytochalasin D for 3 h. Graphs show the results for one representative experiment: eight wells of 100–200 cells each were analysed per sample.
Experiment was repeated with similar results. Bars—means±s.e.m. (n¼ 8; **Po0.01, *Po0.05; two-tailed t-test) (d) Cathepsin L (CTSL) activity in HeLa
cells treated with the indicated drugs (1 mM, 3 h). Baﬁlomycin was positive control (400nM, 3 h). Bars—means±s.d. (n¼ 3; ***Po0.001, **Po0.01;
two-tailed t-test). (e) Cathepsin D (CTSD, anti-mouse Alexa 488) and LAMP1 (anti-rabbit Alexa 568) double-immunostaining in cells treated with
latrunculin A (1 mM, 3 h). Bottom graph—colocalization quantiﬁcation. More than 30 cells were counted per experiment (each experiment was performed
at least twice). Bars—mean±s.e.m. (***Po0.001; two-tailed t-test). Scale bar, 10 mm. (f) Cathepsin D (anti-mouse Alexa 488) and calnexin (anti-rabbit
Alexa 568) double-immunostaining in latrunculin A-treated cells (1 mM, 3 h). Bottom panel—colocalization quantiﬁcation. More than 30 cells were counted
per experiment (each experiment was performed at least twice). Bars—means±s.e.m. (***Po0.001; two-tailed t-test). Scale bar—10 mm. (g) Lysosomal
pH in cells treated with actin disrupting drugs (latrunculin A, cytochalasin D; 3 h, 1 mM) in full medium. Baﬁlomycin A1—positive control for increased
lysosomal pH. More than 50 cells were counted per experiment, performed twice. Bars—means±s.e.m., where DMSO control was set up to 1 (arbitrary
units) (***Po0.001, *Po0.05; two-tailed t-test). (h–j) mRFP-LC3 and Lgp120-GFP live-cell imaging in HeLa cells exposed to Latrunculin A (1mM).
Autophagosome–lysosome fusion is not affected compared with the control. Scale bar, 10mm. (i) mRFP-LC3 and Lgp120-GFP colocalization expressed as
Pearson’s coefﬁcient. More than 25 cells were counted per experiment. Bars—means±s.e.m. (NS, not signiﬁcant; two-tailed t-test). (j) Autophagosome–
lysosome fusion events in HeLa cells expressing mRFP-LC3 and Lgp120-GF. For both control and Latrunculin A treatment, the movies show ﬁve frames
compressed per second (from a total of 70 frames, taken continuously). Arrows—fusion events. Scale bar, 10mm.
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Figure 4 | CCTcontrols lysosomes biogenesis via actin cytoskeleton. (a) LC3-II blots of HeLa cells treated with CCT5 siRNA and exposed to latrunculin A
(1mM, 3 h). (b) LC3-II/GAPDH densitometry in HeLa cells treated as in a. Bars—means±s.d. (n¼ 3; *Po0.05, NS, not signiﬁcant; two-tailed one sample
t-test). (c) In vitro cathepsin L (CTSL) activity in HeLa cells exposed to CCT5 siRNA. Fluorescence intensity expressed as percentage of control. The cells
were additionally exposed to Latrunculin A (3 h, 1 mM). Bars—means±s.d. (n¼ 3; ***Po0.001, **Po0.01, NS, not signiﬁcant; two-tailed t-test). (d) In vitro
cathepsin L activity in HeLa cells exposed to CCT2 or CCT7 siRNAs. Fluorescence intensity was expressed as percentage of control. The cells were
additionally exposed to Latrunculin A (3 h, 1 mM). Bars—means±s.d. (n¼ 3; ***Po0.001, **Po0.01, NS, not signiﬁcant; two-tailed t-test). (e) LC3-II levels
in HeLa cells exposed to two rounds of PFD6 (prefoldin) smart-pool siRNA treatments in the presence/absence of Baﬁlomycin A1 (400nM, 3 h).
(f) LC3-II/GAPDH densitometry for HeLa cells exposed to two rounds of PFD6 (prefoldin) smart-pool siRNA and treated as in e. Bars—means±s.d. (n¼ 3;
*Po0.05, NS, not signiﬁcant; two-tailed one sample t-test). (g) LC3-II blots of HeLa cells treated with individual PFD6 siRNA oligos in presence/absence of
Baﬁlomycin A1 (400nM, 5 h). LC3-II/GAPDH ratio is displayed relative to control. (h) Cathepsin L activity in HeLa cells treated as in e. Baﬁlomycin A1 was
positive control (400nM, 3 h). Bars—means±s.d. (n¼ 3; ***Po0.001, **Po0.01, NS, not signiﬁcant; two-tailed t-test). (i) Number and size of GFP dots
(autophagosomes) and mRFP-only dots (autolysosomes). HeLa cells stably expressing mRFP-GFP-LC3 were treated with two rounds of siRNA (smart-pool
PFD6 and two individual oligos), then seeded in a 96-well plate and subjected to Cellomics visualization analysis. Graphs show the results for one
representative experiment: 10 wells of 100–200 cells each were analysed per sample. Similar data was seen in other two independent experiments.
Bars—means±s.e.m. (n¼ 10; ***Po0.001, **Po0.01, *Po0.05; two-tailed t-test).
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folding, recapitulated the major defects caused by CCT depletion
or treatment with actin depolymerizing drugs (Fig. 4e–i). PFD6
knockdown reduced both autophagosome degradation and ﬂux
(quantiﬁed as LC3-II levels on western blot—Fig. 4e–g, or as
number/size of yellow vesicles in HeLa cells stably expressing the
mRFP-GFP-LC3 reporter—Fig. 4i) and cathepsin L activity
(Fig. 4h). As in the case of CCT knockdown, latrunculin A failed
to further reduce cathepsin L activity in PFD6 knockdown cells
(Fig. 4h), reinforcing the role of actin in the autophagy–lysosome
impairment found in both CCT- and prefoldin-deﬁcient condi-
tions. Thus, CCT knockdown appears to block the autophagy ﬂux
mainly through actin cytoskeleton-dependent mechanisms.
CCT restricts mutant HTT accumulation via autophagy.
CCT2/5/7 depletions increased the percentage of cells with
mutant huntingtin exon 1 EGFP-HTT(Q74) (exon 1 of HTT with
a 74-polyglutamine expansion fused at its N-terminal to EGFP)
aggregates and cell death (scored by assessing proportion of cells
with apoptotic nuclei, which correlates well with other assays and
which we have used extensively33,34) in autophagy-competent
HeLa (ATG16L1þ ) cells (Fig. 5a, both upper and bottom
panels; Supplementary Fig. 8a). This phenomenon occurs when
autophagy is compromised1,35, and presumably also if chaperone
activity is impaired10,11.
Previous studies10,11,36 had assumed CCT regulates huntingtin
aggregation by direct binding and modulation of its folding,
suggesting that this chaperone directly regulates the aggregation
of many intracellular disease-associated aggregate-prone proteins.
However, our data suggested that autophagy insufﬁciency could
also account for this phenomenon. Indeed, CCT depletion was
unable to increase the percentage of cells with EGFP-HTT(Q74)
aggregates or apoptotic nuclei compared with control in
autophagy-deﬁcient HeLa cells (ATG16L1 ) where ATG16L1
has been depleted using the CRISPR/Cas9 genome-editing
technique to compromise autophagy (Fig. 5b, both upper and
bottom panels; Supplementary Fig. 8b–d). The ATG16L1 HeLa
cells depleted for various CCT subunits were exposed in parallel
to 2 different concentrations of EGFP-HTT(Q74) plasmid (1 mg
in Fig. 5b and 0.5 mg in Supplementary Fig. 8c). At both
concentrations, CCT2/5/7 subunit depletions had a similar effect
and caused no increase in the percentages of the cells with
aggregates compared with control. Moreover, the transfections
with different EGFP-HTT(Q74) plasmid concentrations
gave a dose-dependent increase in the percentages of cells with
aggregates in control and CCT subunit knockdown cells (B20%
compared with 10% when used 1 or 0.5 mg EGFP-HTT(Q74)
concentration, respectively—see Fig. 5b; Supplementary Fig. 8c).
This phenomenon is the same as we have observed previously37.
Those ﬁndings were next conﬁrmed in another cell line—mouse
embryonic ﬁbroblasts (MEFs), where lentiviral transduction
of Cct5 shRNAs increased the number of cells with aggregates/
apoptotic nuclei in wild-type cells (WT), but failed to do so in the
autophagy incompetent Atg16L1 / MEFs (Fig. 5c; Supplementary
Fig. 8e).
Our data exclude the interpretation that the system might be
saturated in the autophagy null cells precluding a further increase
in the aggregation/oligomerization levels. We previously reported
that the proportion of autophagy null MEFs with polyglutamine
aggregates can increase when protein clearance pathways other
than autophagy are perturbed38. Our data above show that CCT
inhibition has no effect in ATG16L1 cells transfected with
0.5 mg EGFP-HTT(Q74), yet obtained twice as many ATG16L1
cells with aggregates when they were transfected with 1 mg
EGFP-HTT(Q74)—thus this system was not saturated (Fig. 5b;
Supplementary Fig. 8c). We additionally conﬁrmed that MG132
(a proteasome inhibitor) increases the aggregation in both
ATG16L1þ and ATG16L1 HeLa cells (Supplementary
Fig. 8f,g). The experiment was performed following the same
protocol as when we depleted individual CCT subunits. We
further conﬁrmed that MG132 also increased the percentage
of cells with aggregates in the Atg16L1 / MEFs at two different
concentrations to a similar extent (Supplementary Fig. 8h).
As these EGFP-HTT(Q74) constructs lack the ﬁrst eight amino
terminal residues of the protein, we also examined the effect of
CCT depletion on the aggregation of two other well-characterized
mutant huntingtin exon 1 fragments which have complete N
termini and C-terminal GFP tags in both the autophagy-
competent and -incompetent cells. This is important as the ﬁrst
17 amino acids of HTT are exposed to post-translational
modiﬁcations involved in modulating the HTT localization and
its clearance by autophagy under ER stress conditions39–41. The
percentages of cells with N17-97QP-GFP and N17-103Q-GFP
aggregates followed the same pattern as previously described for
EGFP-HTT(Q74) aggregates: increased percentage of cells with
visible aggregates upon CCT5 depletion in autophagy-competent
HeLa cells, but no additional effect in autophagy-incompetent
cells (Fig. 5d,e; Supplementary Fig. 8i). Moreover, CCT2
co-immunoprecipitated with all these huntingtin-exon1
fragments: EGFP-HTT(Q74) (Fig. 5f), N17-97QP-GFP and
N17-103Q-GFP (Fig. 5g).
Thus, these data suggest that autophagy is the main contributor
to the excess EGFP-HTT(Q74) aggregation in CCT knockdown
cells (proteasome activity was not affected by the CCT knock-
down (Supplementary Fig. 8j)). As previously reported35,36, the
morphological characteristics (as size and cellular localization) of
EGFP-HTT(Q74), N17-97QP-GFP or N17-103Q-GFP aggregates
in cells exposed to CCT2/5/7 siRNAs were indistinguishable from
those in control cells, and also between autophagy -competent
and -incompetent conditions (Supplementary Fig. 9a,b, related to
Fig. 5a–e).
We next examined if CCT loss-of-function impacted the
oligomerization of htt upstream of aggregate formation through
autophagy and to which extent this would inﬂuence the
formation of toxic intermediate species. As expected, knockdown
of CCT5 subunit signiﬁcantly increased the amount of
co-immunoprecipitation of monomeric GFP-C-terminus-tagged
mutant HTT(1–548) with Flag-N-terminus-tagged mutant
HTT(1–588) and vice versa in HeLa cells, compared with control,
as a measure of dimerization/oligomerization (Fig. 6a,b).
Consistent with our aggregate counting data in Fig. 5a–e,
knockdown of CCT5 had no effect on the mutant htt
dimerization compared with control in autophagy-incompetent
cells (Fig. 6a–c; Supplementary Fig. 9c). Additionally, treatment
with MG132 was able to further increase the htt dimerization in
ATG16L1 HeLa cells (Supplementary Fig. 9d), suggesting that
the htt oligomerization is not saturated in the autophagy-
incompetent cells. As expected, CCT2 co-immunoprecipitated
with both the WT or mutant HTT(1–548) tagged to GFP at its C
terminus (Fig. 6d).
To strengthen this observation, we next measured the
abundance of pathogenic species with toxic conformations
formed in the diffuse htt fraction of HeLa cells overexpressing
Flag-tagged HTT(1–588) using the antibody 3B5H10, which
recognizes a compact, two stranded conformation of polyQ
in monomeric soluble mutant htt42,43. This monoclonal
conformation-speciﬁc antibody recognizes soluble mutant htt
species that predict neurodegeneration42,43. The cells exposed to
CCT5 siRNA showed increased 3B5H10 intensity compared with
control in ATG16L1þ cells, but not in ATG16L1 HeLa cells
(Fig. 6e,f), suggesting that also the pool of soluble toxic species
follow the same pattern as the aggregation and oligomerization
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms13821
8 NATURE COMMUNICATIONS | 7:13821 | DOI: 10.1038/ncomms13821 | www.nature.com/naturecommunications
0
2
4
6
8
10
12
14
Ctrl CCT2
KD
CCT5
KD
CCT7
KD
** *
*
HeLa (ATG16L1+)
0
5
10
15
20
25
Ctrl CCT2
KD
CCT5
KD
CCT7
KD
ATG16L1–
NS
0
2
4
6
8
10
12
14
16
18
Ctrl sh#1
Cct5 sh#1
Cct5 sh#2
*
***
NS
0
5
10
15
20
25
Ctrl CCT2
KD
CCT5
KD
CCT7
KD
* **
*
0
5
10
15
20
25
30
35
Ctrl CCT2
KD
CCT5
KD
CCT7
KD
NS
%
 o
f c
el
ls 
wi
th
 a
bn
or
m
al
n
u
cl
ei
 m
or
ph
ol
og
y
%
 o
f c
el
ls 
wi
th
 a
bn
or
m
al
n
u
cl
ei
 m
or
ph
ol
og
y
0
2
4
6
8
10
12
14
16
18
WT MEFs
Ctrl sh#1
Cct5 sh#1
Cct5 sh#2
%
 o
f M
EF
s 
wi
th
 a
bn
or
m
al
n
u
cl
ei
 m
or
ph
ol
og
y **
*
NS
Pe
rc
en
ta
ge
 o
f c
el
ls 
wi
th
EG
FP
-H
TT
(Q
74
) a
gg
reg
ate
s
Pe
rc
en
ta
ge
 o
f M
EF
s 
wi
th
EG
FP
-H
TT
(Q
74
) a
gg
reg
ate
s
0
50
100
150
200
250 Ctrl
CCT5 KD
*
NS
0
50
100
150
200
250 CtrlCCT5 KD
NS
**
d
e
CCT2
GFP
GFP
CCT2
GF
P-v
ect
or
GF
P-v
ect
or
EG
FP
-HT
T(Q
74)
GF
P-v
ect
or
EG
FP
-HT
T(Q
74)
N1
7-1
03
Q-G
FP
N1
7-9
7Q
P-G
FP
GF
P-v
ect
or
N1
7-1
03
Q-G
FP
N1
7-9
7Q
P-G
FP
f
IP: GFP
Total
lysates
Ct
rl
CC
T5
 K
D
ATG16L1+ ATG16L1–
Ct
rl
CC
T5
 K
D
g
IP: GFP
Total
lysates
N17-103Q-GFP
DAPI
70
55
35
55
25
55
70
55
35
%
 G
FP
-p
os
itiv
e 
 H
eL
a 
ce
lls
 w
ith
N
17
-1
03
Q-
GF
P 
ag
gr
eg
at
es
%
 G
FP
-p
os
itiv
e 
 H
eL
a 
ce
lls
 w
ith
N
17
-Q
97
QP
-G
FP
 a
gg
re
ga
te
s
ATG16L1+ ATG16L1–
ATG16L1–
ATG16L1–ATG16L1+
N17-97QP-GFP
DAPI
ATG16L1+
HeLa (ATG16L1+) ATG16L1–
Atg16L1–/–
MEFs
WT MEFs Atg16L1–/–
MEFs
%
 o
f A
TG
16
L1
-c
e
lls
 w
ith
EG
FP
-H
TT
(Q
74
) a
gg
reg
ate
s
a b c
Figure 5 | CCTdepletion increases PolyQ aggregation consequently to reduced autophagic clearance. (a) EGFP-HTT(Q74) aggregation and cell toxicity
in CCT-depleted HeLa cells. Upper: HeLa cells (ATG16L1þ ) were seeded on coverslips in triplicates, transfected with siRNAs targeting control or individual
CCT subunits, followed by 1mg of EGFP-HTT(Q74) overexpression. Bottom: percentage of nuclei with morphological changes (fragmented or condensed
nuclei). Bars—means of percentages of cells with aggregates±s.d. (n¼ 3; **Po0.01; *Po0.05; two-tailed t-test). Similar results were observed in four
independent experiments. See Supplementary Fig. 9b for representative images. (b) EGFP-HTT(Q74) aggregation and cell toxicity in ATG16L1
CRISPR/Cas9 HeLa cells. The experiment was performed in parallel with a. Bars—means of percentages of cells with aggregates±s.d. (n¼ 3; NS, not
signiﬁcant; two-tailed t-test). Similar results were observed in four independent experiments. See Supplementary Fig. 9b for representative images.
(c) EGFP-HTT(Q74) aggregation and cell toxicity in WT and Atg16L1 / MEFs. Cells were seeded on coverslips in triplicates, transduced with lentiviral
particles targeting control or the mouse Cct5 subunit (two independent shRNAs) and transfected with EGFP-HTT(Q74). Bars—means of percentages of
cells with aggregates±s.d. (n¼ 3; ***Po0.001, **Po0.01, *Po0.05, NS, not signiﬁcant; two-tailed t-test). Similar data was achieved in 3 independent
experiments. See Supplementary Fig. 9a for representative images. (d) N17-103Q-GFP aggregation in CCT-depleted ATG16L1þ and ATG16L1 HeLa cells.
Representative images of N17-103Q-GFP aggregates are displayed on right. Bars—mean of the percentages of cells with aggregates±s.e.m. (n¼4
independent experiments, each performed in triplicates; **Po0.01, NS, not signiﬁcant; one sample t-test). (e) N17-97QP-GFP aggregation in CCT-depleted
ATG16L1þ and ATG16L1 HeLa cells. Representative images of N17-103Q-GFP aggregates are on right. Bars—mean of the percentages of cells with
aggregates±s.e.m. (n¼4 independent experiments, each performed in triplicates; **Po0.01, NS, not signiﬁcant; one sample t-test). (f) CCT
co-immunoprecipitation with EGFP-HTT(Q74). HeLa cells were transfected with either GFP-vector or EGFP-HTT(Q74) for 16 h and GFP-tagged proteins
were pulled-down with GFP-Trap. (g) CCT co-immunoprecipitation with N17-103Q-GFP and N17-97QP-GFP. HeLa cells were transfected with GFP-vector,
N17-103Q-GFP or N17-97QP-GFP for 16 h and GFP-tagged proteins were pulled-down with GFP-Trap. Note: N17-103Q-GFP does not have the proline-rich
domain, while N17-97QP-GFP has both N terminus and proline-rich domains of htt exon 1.
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Figure 6 | CCT depletion increases PolyQ oligomerization consequently to reduced autophagic clearance. (a,b) Oligomerization of mutant htt in
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autophagy incompetent cells: ATG16L1 HeLa. (c) Quantiﬁcation of mutant htt co-immunoprecipitation relative to total lysates/input from three
independent experiments. The control condition was set to 100 and the bars represent the mean±s.d. (n¼ 3; *Po0.05, NS, not signiﬁcant; two-tailed
sample t-test). See Methods. (d) CCTco-immunoprecipitation with the Htt(1–548)Q15 and Htt(1–548)Q138 constructs tagged with GFP at the C terminus.
HeLa cells were transfected with GFP-vector, Htt(1–548)Q15 –GFP or Htt(1–548)Q138-GFP for 48 h and the GFP-tagged proteins were pulled-down using
the GFP-Trap technology. (e) 3B5H10 staining in CCT5-depleted HeLa cells, both ATG16L1þ and ATG16L1 . Scale bar throughout the panel is 10mm. See
Methods. (f) Quantiﬁcation of 3B5H10 to Flag ratio signal intensities from three independent experiments. The bars represent the mean±s.d. (n¼ 3;
*Po0.05, NS, not signiﬁcant; two-tailed sample t-test). (g) 3B5H10 antibody preferentially label cells overexpressing the pathogenic polyQ expansions in
Htt(1–588). HeLa cells were transiently transfected with either Flag-tagged HTT(1–588)Q138 or Flag-tagged HTT(1–588)Q15 and immunostained with
3B5H10 antibody. Scale bar throughout the panel is 10mm.
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data. Fig. 6g validates that this antibody preferentially detects
mutant htt species and not wild-type htt, as described
previously42,43. Therefore, at this point, we concluded that the
autophagy defect is the primary mechanism underlying the excess
mutant htt oligomerization and aggregation when CCT2/5/7
functions are grossly impaired.
CCT controls ATXN3 and p62 accumulation via autophagy. We
next questioned whether this observation could be extended to
other autophagy substrates44,45 in multiple cell lines: HeLa, MEFs
and primary cortical neurons. In autophagy-competent cells,
CCT5 silencing enhanced the aggregation of transiently
expressed GFP-tagged ATXN3(Q84) in HeLa cells (ataxin 3
protein with an expanded polyglutamine tract which causes
spinocerebellar ataxia type 3 (ref. 46)) (Fig. 7a,b; Supplementary
Fig. 10a), or long polyalanine tract EGFP-A19 (Fig. 7c) in MEFs
and increased the levels of the endogenous autophagy substrate
p62 in HeLa cells, primary cortical neurons and MEFs
(Supplementary Fig. 10b–d). CCT2 or CCT7 depletion also
increased the p62 levels in HeLa cells (Supplementary Fig. 10b).
Similar to the mutant huntingtin-exon1 aggregation data,
CCT2/5/7 knockdowns had no additional effect on the
accumulation of these autophagy substrates in autophagy-
deﬁcient cells compared with controls (Fig. 7; Supplementary
Fig. 10a,d). However, as p62 is also a proteasome substrate, we
checked the p62 levels in Atg16L1 / MEFs when treated with
MG132 and showed the autophagy-independent increase of p62
in this cell line (used as a positive control for increased p62 levels
in autophagy incompetent cells—see Supplementary Fig. 10e).
Thus, the p62 readout is not saturated. As in the mutant
huntingtin-exon1 experiments, GFP-ATXN3(Q84)- or EGFP-
A19-transfected cells did not show any differences in
morphologies of the aggregates between the control or CCT5-
depleted cells (Fig. 7b; Supplementary Fig. 10f). Interestingly,
CCT2 strongly co-immunoprecipitated with all these additional
autophagy substrates used: polyA, GFP-ATXN3(Q84) and GFP-
p62 (Fig. 7d).
The autophagy inducers carbamazepine47,48 or Tat-Beclin1
peptide49, which enhance autophagosome biogenesis,
signiﬁcantly reduced the percentage of control cells with
mutant htt aggregates. These inducers had no effects on the
percentage of ATG16L1-null cells with mutant htt aggregates,
thus these phenomena are autophagy-dependent. These inducers
also had no effect on the percentage of CCT5-knockdown cells
with mutant htt aggregates (Supplementary Fig. 10g). This is
entirely consistent with our model suggesting that the
predominant effects of CCT depletion on autophagy is at the
level of the lysosome. In this scenario, induction of
autophagosome biogenesis will be unable to signiﬁcantly
modulate degradation of substrate, as the block in the pathway
is downstream of autophagosome formation. Furthermore, these
data underscore the impact of the autophagy–lysosome pathway
defect in CCT depletion, since if the autophagy–lysosome defect
were mild or if the predominant effect of the individual
CCT subunits depletions on the aggregation were via an
autophagy–lysosome-independent mechanism, then autophagy
induction would be able to reduce the levels of mutant huntingtin
aggregation.
As lysosomal function is important for degradation of both
autophagic and endocytic cargos and as depletion of individual
CCT subunits reduces lysosomal activity (by increasing the
lysosomal pH and impairing the trafﬁcking of lysosomal
enzymes as Cathepsins D and L), we next examined whether
CCT5 depletion caused the accumulation speciﬁc endocytic
cargos. Indeed, the levels of IGF1R, EGFR and b1 integrin
increased in CCT5 depleted HeLa cells (Supplementary Fig. 11a).
We conﬁrmed that EGFR degradation kinetics (see Methods) was
signiﬁcantly retarded down in CCT5 knockdown cells,
suggesting that the endocytic-lysosomal degradation route is
perturbed (Supplementary Fig. 11b). However, we cannot
exclude the possibility that these proteins could be clients of
CCT/TRiC, thereby preventing proper refolding and reducing
clearance.
CCT depletion blocks autophagosome degradation in Drosophila.
We further explored these phenomena in vivo using Drosophila,
where we downregulated the CCT5 homologue, Cct5, using two
independent RNA interference (RNAi) lines (Cct5KK or Cct5NIG,
whose sequences do not overlap) or the CCT7 homologue, Cct7,
using the Cct7KK RNAi line (full genotypes of RNAi lines are in
Methods). Fat body cells of male third instar larvae (L3) depleted
of Cct5 or Cct7 RNAi showed consistent increases in the
endogenous Atg8a-II (orthologue to the human LC3-II) levels
and in size of mCherry-Atg8a vesicles compared with controls
(Fig. 8a–c; Supplementary Fig. 12a). Additionally, levels of both
endogenous and GFP-tagged Ref(2)P, the Drosophila p62
orthologue, were increased 5-fold in Cct5- or Cct7-knockdown
ﬂies, consistent with defective autophagic clearance (Fig. 8a,d,e;
Supplementary Fig. 12a–c). However, in autophagy-defective
Atg8aKG07569 larval fat bodies, RNAi depletion of either Cct5
or Cct7 did not increase the levels of both GFP-tagged and
endogenous p62 levels compared with control (Fig. 8a,d,f;
Supplementary Fig. 12a). At a macroscopic scale, both
Cct-depleted and Atg8aKG07569 larvae showed a necklace-like
phenotype in the fat body, where regions with bigger Ref(2)P
aggregates alternated with less bright ones (Supplementary
Fig. 12d). The autophagy phenotype seen in Cct5- and
Cct7-depleted larval fat body cells is similar to the one described
in literature for V-ATP-ase depletion27, consistent with the
mechanism described in mammalian cells. These data suggest
that the Ref(2)P/p62 aggregation seen in vivo systems depleted for
Cct5 or Cct7 is autophagy dependent (Fig. 8; Supplementary
Fig. 12a).
Discussion
The activity of the chaperonin CCT/TRiC is impaired in
devastating neuropathies and in Alzheimer’s disease and has
been proposed to regulate the aggregation of proteins like mutant
huntingtin. We therefore investigated and focused on loss-of-
CCT-function experiments, as those probe for the physiological
roles of the complex. Our ﬁndings identify important cross-talk
between two key components of the proteostasis network, since
CCT is essential for optimal lysosome activity, and if impaired,
then the consequent reduction in autophagosome ﬂux results in
the accumulation, oligomerization and aggregation of various
disease-relevant autophagy substrates.
Our results suggest that the autophagy–lysosome inhibition is
largely mediated by defective folding of actin. Both actin
dysregulation and CCT dysfunction cause impairment of
lysosomal activity and reduce autophagosome formation. As the
autophagosome-degradation impairment overwhelms any addi-
tional inhibition of autophagosome biogenesis in CCT-depleted
conditions, we focused on studying and elucidating the mechan-
ism behind LC3 accumulation and its consequences on protein
degradation. Autophagy–lysosome compromise is sufﬁcient to
cause the accumulation and excess aggregation of proteins like
mutant huntingtin, p62 and mutant ATXN3 (refs 35,45,50).
Defects in the lysosomal compartment would be predicted to
interfere with both autophagic and endocytic routes. Indeed,
in addition to the accumulation of well-characterized autophagy
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Figure 7 | CCT depletion increases the accumulation of diverse autophagy substrates. (a) GFP-ATXN3(Q84) aggregation in CCT-depleted ATG16L1þ
and ATG16L1- HeLa cells. The bars represent the mean of the percentages of cells with aggregates±s.e.m. (n¼4 independent experiments, each performed
in triplicates; ***Po0.001, NS, not signiﬁcant; one sample t-test). (b) Representative images of GFP-ATXN3(Q84) aggregates for the experiments
performed in a. Scale bar throughout the panel is 10 mm. (c) EGFP-A19 aggregation in WTand Atg16L1 / MEFs. Cells seeded on coverslips in triplicates,
were transduced with two different shRNA lentiviral particles targeting either control or the mouse Cct5 subunit and transfected with EGFP-A19. The bars
represent the mean of percentages of cells with aggregates±s.d. (n¼ 3; *Po0.05, NS, not signiﬁcant; two-tailed t-test). Similar data was achieved in other
two independent experiments. (d) CCT co-immunoprecipitation with the GFP-ATXN3(Q84), GFP-p62 (on the left ) and EGFP-A19, N17-97QP-GFP
(on the right). HeLa cells were transfected with GFP-vector or the above mentioned proteins tagged to GFP for 16 h; the GFP-tagged proteins were
pulled-down using the GFP-Trap technology. (e) Western blotting for p62. ATG16L1þ and ATG16L1 CRISPR/Cas9 HeLa cells were transfected with
siRNA targeting individual CCT subunits. GAPDH was used as loading control. (f) Quantiﬁcation of p62 accumulation. ATG16L1þ and ATG16L1
CRISPR/Cas9 HeLa cells were transfected with siRNA targeting individual CCT subunits as in (e). GAPDH was used as loading control. The bars
represent the mean±s.d. (n¼ 3; **Po0.01, *Po0.05, NS, not signiﬁcant; two-tailed one sample t-test). Similar results were observed in three independent
experiments.
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substrates, we also noticed an increase in endocytic cargos like
IGF1R, EGFR and B1 integrin and slowed kinetics of EGFR
degradation. However, we cannot exclude any direct chaperoning
effect on CCT on these proteins which may also inﬂuence their
fates.
CCT1 was previously shown to interact and sequester the
N17-huntingtin exon 1 fragments10–12 as well as polyQ
stretches51. Here we conﬁrmed that CCT2 interacted with
huntingtin fragments, polyA stretches, mutant ATXN3 and p62.
It is not clear if the htt-CCT2 interaction is dependent on the N17
amino acids of htt, like CCT1 (refs 10–12,14). It is interesting that
the co-immunoprecipitation of CCT2 with the HTT-exon1
fragment is reduced in the presence of the proline-rich region
compared with the HTT-exon1 without prolines (Fig. 5g)—this
observation could be relevant to both the interaction and the
effects described. Exon 1 of HTT also appears to assist in
targeting huntingtin to autophagosomes and regulating HTT
clearance by the lysosomal and proteasome pathways39–41. In
future work, it would be interesting to evaluate the impact of
HTT N17 phosphorylation on the type of autophagy modulated
by CCT (for example, selective versus bulk autophagy),
as CCT and HTT may work together in autophagy and htt
phosphorylation appears to modify its interactions39,52,53.
This might be important as WT huntingtin also functions as
scaffold for selective autophagy44,54.
CCT was previously shown to interact with various compo-
nents of the autophagic machinery involved in phagophore
elongation, such as ATG16L1, ATG5, ATG10, ATG3 and
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Figure 8 | The increase of p62 levels and aggregation after Cct5 depletion in Drosophila is autophagy dependent. (a) Biochemical assessment of
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ﬁve larvae per each condition, 425 cells per larva. Size of mCherry-Atg8a-positive vesicles increased in Cct5-depleted cells, suggesting defective
autophagosome degradation. (n¼ 5; NS, not signiﬁcant, *Po0.05; **Po0.01; two-tailed t-test). Scale bar, 10 mm. (c) Atg8a-II levels in third instar larval fat
bodies upon knockdown of Cct5 using Cg-GAL4, as in c. Bars—means±s.e.m., control ratio set to 100 (*Po0.05; two-tailed one sample t-test).
(d) Quantiﬁcation of GFP-tagged and endogenous Ref(2)P levels in third instar larval fat bodies upon knockdown of Cct5 using Cg-GAL4 as in c, either alone
(top graphs), or in an Atg8a mutant background (Atg8aKG07569;Cct5KK, bottom graphs ). Bars—means±s.e.m., control ratio set to 100 (NS, not signiﬁcant,
**Po0.01, ***Po0.001; two-tailed one sample t-test). (e) Representative confocal images showing GFP-Ref(2)P in fat body of Cct5 knockdown (using
Cg-GAL4) third instar larvae. GFP-Ref2(P)-positive aggregates accumulate in Cct5-depleted cells. TO-PRO-3 stains the nuclei. Experiment was repeated
with similar results (n43). Scale bar, 10mm. (f) Representative confocal images showing GFP-Ref(2)P in larval fat body cells co-depleted for both Atg8a
and Cct5 (Atg8aKG07569;Cct5KK109505). Cct5 knockdown did not obviously enhance the GFP-Ref(2)P phenotype of Atg8a mutants. Experiment was repeated
with similar results. TO-PRO-3 stains the nuclei. Scale bar, 10mm.
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TECPR1 (ref. 55). These may be relevant to the decrease in
autophagosome biogenesis seen in CCT knockdown cells.
Our data extend beyond the CCT–HTT interaction10–12,51,
as we have seen similar interactions with other autophagy
adaptors/cargos such as ATXN3, p62 or polyA tract that indeed
accumulate in a similar autophagy-dependency pattern upon
CCT depletion. The effects of the CCT depletion on the
aggregation and oligomerization of mutant huntingtin
fragment, polyalanine expanded proteins, mutant ATXN3 and
p62 are primarily autophagy dependent, as opposed to the
current assumption that these proteins are direct clients of
physiological CCT activity and that this direct chaperone activity
on mutant huntingtin is entirely responsible for its anti-
aggregation properties (Figs 5 and 6). If the latter were critical,
then one may expect that knockdown of CCT subunits would
further enhance the aggregation/oligomerization/soluble toxic
species accumulation of mutant huntingtin and related substrates
in autophagy-deﬁcient cells and Drosophila (see schema in
Fig. 9a). Likewise, agents that induce autophagy at the level of
autophagosome formation had no signiﬁcant effects on the
proportion of CCT-depleted cells with aggregates, which is what
one would expect when there are major defects at the
downstream lysosomal stages (Fig. 9b). Since autophagy
activators would be expected to reduce the aggregation
phenotype if CCT depletion acted only partly via the
autophagy–lysosome pathway, or if the lysosomal defect still
enabled some increased autophagy substrate ﬂux upon induction
of autophagosome biogenesis, these data reinforce the concept
that the predominant consequence of CCT depletion on htt
aggregation is by compromise of the autophagy–lysosome
pathway. While we do not exclude that proteins like mutant
huntingtin are direct CCT substrates or that overexpression
of components of this complex may assist appropriate mutant
huntingtin folding, our experiments suggest that loss of
physiological CCT complex activity affects the mutant
huntingtin, ataxin 3 and p62 accumulation, aggregation or
toxicity mainly as a consequence of autophagy impairment, and
that the contribution of any loss of direct endogenous chaperone
complex activity on mutant huntingtin, p62 or ataxin 3 is
minimum (undetectable) in our systems. We have not speciﬁcally
tested CCT1 in our studies, and therefore cannot conclusively
exclude that CCT1 acts in part through direct inhibition of htt
aggregation. This is possible, since the ApiCCT1 domain alone is
unlikely to be working through an alteration of CCT activity, as it
lacks the domains responsible for the formation of the TRiC
complex, having only the Apical client interaction domain10–12,14.
However, our data are most relevant to the activity of the CCT
complex as a whole.
As we used GFP-tagged constructs in most of our experiments,
GFP tags may inﬂuence the degradation route options available to
such proteins, for instance by increasing oligomerization and
shifting ﬂux from the proteasome to autophagy or by inﬂuencing
phosphorylation events in htt that inﬂuence its clearance52,56,57.
However, it is important to point out that the clearance of these
GFP-fusions are autophagy-dependent as are the clearance of
untagged mutant htt58, mutant ataxin 3 (ref. 59) and p62 (ref. 50).
Importantly, the accumulation and aggregation of proteins
in autophagy-defective mouse brains is sufﬁcient to cause
neurodegeneration60,61, and decreased autophagy exacerbates
the aggregation and toxicity of many intracytoplasmic
aggregate-prone proteins, suggesting that the autophagy
impairment resulting from CCT inhibition is sufﬁcient to be a
major driver of pathology. Therefore, pathological conditions
with downregulated levels of CCT (for example Alzheimer’s
disease6) might manifest proteostasis disruption in both the
chaperone and autophagy–lysosome systems. While this model is
consistent with our toxicity data in cell culture models, it is likely
that other direct clients of this chaperone will accumulate
in misfolded states in such cells, which will also have
likely deleterious consequences. Furthermore, the pathological
consequences of autophagy impairment likely extend beyond
the accumulation of speciﬁc aggregate-prone proteins to
other phenotypes relevant to Huntington’s disease and other
neurodegenerative diseases, including reduced clearance of
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dysfunctional mitochondria leading to elevated levels of reactive
oxygen species, and increased susceptibility to apoptotic insults1.
Methods
Antibodies. The antibodies used for western blot (WB) and immunoﬂuorescence
include: rabbit polyclonal anti-Calnexin (1:300 IF, Abcam), mouse monoclonal
anti-Cathepsin D (1:200 IF, ab6313 Abcam), mouse monoclonal anti-Cathepsin L
(1:500 WB, 611084 BD Bioscience), rat anti-Cathepsin L (1:1,000 WB, MAB9521
R&D Systems), goat anti-mouse Cathepsin L (1:1,000 WB, AF1515 R&D Systems),
mouse monoclonal anti-GAPDH (1:5,000 WB, ab8245 Abcam), rabbit polyclonal
anti-LC3 (1:3,000 WB, NB100-2220 Novus Biological), mouse monoclonal
anti-LC3 (1:200 IF, clone 5F10 Nanotools), mouse monoclonal anti-LAMP1
(1:0 IF, clone H4A3 Developmental Studies Hybridoma Bank, University of Iowa),
rabbit polyclonal anti-LAMP1 (1:200 IF, ab2417 Abcam), mouse monoclonal anti-
tubulin (T9026 Sigma-Aldrich), 3B5H10 mouse monoclonal anti –polyglutamine
(1:300 IF, P1874 Sigma-Aldrich), anti-Flag (1:1,000 WB, 1:300 IF, F1804 and F7425
Sigma-Aldrich), rabbit polyclonal anti-EGFR (1:250 WB, sc-03 Santa Cruz
Biotechnology), rabbit polyclonal anti-IGF1R (1:250 WB, sc-713 Santa Cruz
Biotechnology), mouse anti b1-integrin (1:1,000 WB, Clone 19/CD29 610467 BD
Biosciences). The CCT antibodies were purchased from Sigma-Aldrich and used at
1:1,000 for WB:mouse monoclonal anti-CCT2 (WH001057M1), mouse mono-
clonal anti-CCT5 (WH0022948M1), rabbit polyclonal anti-CCT7 (HPA008425).
Phalloidin-Alexa Fluor 546 from Invitrogen was used for F-actin staining.
Secondary antibodies for immunoﬂuorescence were conjugates to Alexa Fluor
488, 568, 594 and 647 (Invitrogen). Anti-mouse and anti-rabbit HRP-conjugated
secondary antibodies were from GE Healthcare; LICOR antibodies: anti-mouse 680
and anti-rabbit 800.
Plasmids and siRNAs. Huntington’s disease gene exon 1 fragment with 74 poly-Q
repeats in pEGFP-C1 (Clontech; EGFP-HTT(Q74)) was previously characterized37.
The poly(A) stretch of 19 repeats (A19) tagged with pEGFP (EGFP-A19) was
previously described and characterized35. The N17-97QP-GFP and
N17-103Q-GFP constructs41 were kindly provided by Prof. L.M. Thompson
and Prof. J.S. Steffan (University of California, Irvine). The mutant HTT(1–588)
tagged to Flag at its N terminus was generated by Dr S. Luo62, while the mutant
HTT(1–548) tagged to GFP at its C terminus was a gift from Dr M.R. Hayden
(University of British Columbia)63 and previously characterized by our
laboratory34,62,64. GFP-p62 construct was a gift from Prof. Terje Johansen
(University of Tromso, Norway)50. GFP-ATXN3(Q84) was kindly provided by
Dr. Henry Paulson (Addgene #22123)65. On-Target plus SMART pool siRNA
against human CCT2 (L-020107-00-0005), CCT5 (L-012797-00-0005), CCT7
(L-020115-00-0005), PFD6 (L-020630-02-0005 for smart-pool and LQ-020630-02-
0002 for individual oligos) were purchased from Dharmacon (siRNA nucleotide
sequences are provided in Supplementary Table 1).
Reagents. Baﬁlomycin A1 (Millipore) was resuspended in dimethyl sulphoxide
(DMSO from Sigma-Aldrich) and used at a saturating concentration for
autophagosome degradation of either 400 nM for 4–6 h or 200 nM left overnight.
As Baﬁlomycin A1 is dissolved in DMSO, all conditions without BafA1 received an
equivalent volume of DMSO. Latrunculin A (L5163) and Cytochalasin D (C8273)
were purchased from Sigma-Aldrich, resuspended in DMSO and used at a ﬁnal
concentration of 1 mM in the culture media. MG132 (M8699) and Carbamazepine
(C4024) were purchased from Sigma-Aldrich. Tat-Scrambled and Tat-Beclin1 were
purchased from Protein Chemistry Technology Core, UT Southwestern Medical
Center.
Cell culture. HeLa cells and MEFs were grown in DMEM (D6546 Sigma-Aldrich)
supplemented with 10% fetal bovine serum, 100Uml 1 penicillin–streptomycin,
2mM L-glutamine (all from Sigma-Aldrich) at 37 C and 5% CO2, humidiﬁed
atmosphere. HeLa cells (source ATCC) were authenticated by STR proﬁling. HeLa
cells stably expressing either mRFP-GFP-LC3 or GFP-LC3 were grown in the same
media supplemented with 600mgml 1 of G418 (1181-031 Invitrogen). WT and
Atg16L1 / MEFs66 were kindly provided by Prof. Tamotsu Yoshimori (Osaka
University).
Mouse primary cortical neurons were cultured as described by Jimenez-Sanchez
et al.34 All the cell lines were routinely tested for mycoplasma contamination.
CRISPR/Cas9 HeLa generation line for ATG16L1. HeLa CRISPR/Cas9 ATG16L1
knockout cell lines were generated by double nickase to avoid off target activity
following the methods described in Ran et al.67 and Ran et al.68 Brieﬂy, guide pairs
nicking the ﬁrst exon of ATG16L1 (192–211 and 146–166) were designed using the
Zhang lab CRISR design tool (http://www.genome-engineering.org/crispr/) and
cloned into the pSpCas9n(BB)-2 A-GFP (PX461: Addgene 48410). gRNAs with
overhangs were annealed as described in Ran et al.67 without phosphorylation
and PX461 was digested with BbsI for 1 h followed by ligation in the same step
for another hour (based on ‘ELAN’ method described by Cost and Cozzarelli69).
HeLa cells were transfected with both gRNAs simultaneously or with the equivalent
amount of empty PX461. Two days after transfection, GFP-positive cells were
single-cell sorted into 96-well plates using ﬂuorescent-activated cell sorting (FACS).
Clones were expanded and those where ATG16L1 was undetectable by western
blotting were selected. Empty Cas9 plasmid transfected cells subjected to the same
procedure were used as WT HeLa control cells.
mRFP-GFP-LC3 neurons. All studies and procedures were performed under the
jurisdiction of appropriate Home Ofﬁce Project and Personal animal licenses and
with local Ethics Committee approval. mRFP-GFP-LC3 was subcloned by PCR
from pmRFP-EGFP-rLC3 (gift from T. Yoshimori) into pCAGGS (gift from J. de
Belleroche) which drives ubiquitous expression of the transgene under the control
of a chicken beta-actin promoter and cytomegalovirus enhancer. The vector was
digested with HindIII and SpeI to remove the DNA backbone and the fragment
puriﬁed by gel extraction and used for microinjection into hybrid B6CBA oocytes
as described in Behringer (ref. 70). Founders were identiﬁed by PCR from ear
biopsies and crossed to C57BL6 mice to obtain F1s. mRFP-GFP-LC3 protein
expression level was assessed by western blotting in brain, muscle and tissue and by
cryosectioning of fresh frozen tissue and direct observations of ﬂuorescence levels.
Line 1 was selected for further study due to its good levels of protein expression and
clear ﬂuorescence in brain. This line was maintained by further backcrossing to
C57BL6 mice.
For primary mRFP-GFP-LC3 cortical neurons, transgenic mice were crossed
with C57BL6 mice, at E16.5 gestation females were sacriﬁced and embryos were
harvested. Cortices from all embryos (regardless of genetic status) and combined to
create mixed cultures. Neurons were cultured as described by Jimenez-Sanchez
et al.34 At DIV9-10 mRFP-GFP-LC3 neurons are imaged using confocal
microscopy (63 NA 1.4 Plan Apochromat oil immersion lens; Carl Zeiss
LSM710 and LSM780).
siRNA transfection. In all the siRNA transfection experiments, HeLa cells
were seeded in six-well plates one day before and transfected with 100 nM of the
indicated siRNA using Lipofectamine 2000 (Invitrogen). On the second day the
cells were transfected again with 50 nM of siRNA. At 48 h post transfection the cells
were split and reseeded in 6-well plates according to the experiment’s requirement.
Cells were further cultured in full medium for 48 h. HeLa cells stably expressing the
mRFP-GFP-LC3 reporter were transfected following the protocol above, except
that at 72 h post transfection the cells were reseeded in 96-well plates.
Lentiviral transduction. The following individual shRNAs containing pLKO.1
vectors targeting the mouse Cct5 were purchased from The RNAi Consortium
(TRC): Cct5 sh#1 (TRCN0000120433) and Cct5 sh#2 (TRCN0000120436).
Ctrl sh#1 (lentiviral pLKO.1 Empty Vector Control) was obtained from TRC
(RHS4080) and Ctrl sh#2 (scramble shRNA vector) was previously described by
Jimenez-Sanchez et al.34, available at Addgene, code 1864.
To generate the viruses, we cotransfected actively growing HEK293T with the
target shRNA, the second generation packaging plasmid containing gag, pol and
rev genes and the envelope plasmid (VSV-G expressing plasmid, pMD2.G) using
the TransIT-LT1 transfection reagent (MIR 2300/5/6 Mirus Bio). We harvested
the virus containing the supernatants at 48, 72 and 96 h post-transfection and
concentrated them by centrifugation in 15ml Beckman tubes at 30,000 r.p.m. for
90min at 4 C. The MEFs were plates in 6-well plates and transduced with 40 ml of
the 100 viruses stock on the following day. Forty-eight hours post-transduction
the cells were split and reseeded on coverslips for EGFP-HTT(Q74) overexpression.
Primary neurons were seeded in 12-well plates and transduced with 20 ml of
the 100 viruses stock on day 4 of culture. The media was replaced on the
following day.
Immunoﬂuorescence and microscopy. For double immunostaining studies of
LC3/LAMP1, cytoskeleton or Cathespin D/LAMP1 the cells were ﬁxed and
permeabilized in  20 C cold methanol for 4min. The cells were rinsed several
times in phosphate-buffered saline (PBS) and blocked for 1 h in 0.3% BSA
(BP1605-100 Fischer Scientiﬁc). For immunostaining of LAMP1 (mouse antibody)
and Cathepsin D/Calnexin, the cells were ﬁxed in PFA 4% for 5min, permeabilized
with Triton 0.1% for 10min and then blocked in 3% BSA for 1 h. For Cathepsin D
staining, the cells were incubated in primary antibody buffer for 2 h at 25 C. For
all other immunostaining, the coverslips were left in primary antibody at 4 C
overnight. After a secondary conjugation with Alexa Fluor antibodies for 90min,
the coverslips were mounted in Prolong Gold Antifade reagent (with DAPI;
P-36931 Invitrogen). Coverslips were examined with a confocal microscope
(63 NA 1.4 Plan Apochromat oil immersion lens; Carl Zeiss LSM710, LSM780
and LSM880). When necessary, the images were exported in Photoshop (Adobe)
and equal adjustments were made for all the images from all treatment groups.
3B5H10 antibody staining. The 3B5H10 antibody was previously characterized
as detecting a toxic conformation of htt42,43. ATG16L1þ and ATG16L1 HeLa
cells were exposed to two rounds of control or CCT5 siRNAs and seeded in
12 well plates. The following day, the cells were transfected with 0.4 mg of
Flag-tagged-HTT(1–588) and 5 ml of TransIT-2020 (Mirus) for 18 h, then ﬁxed in
PFA 4% for 5min, blocked for 1 h in 5% goat serum and incubated with primary
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antibodies at 4 C overnight: 3B5H10 (mouse monoclonal, Sigma-Aldrich) and
rabbit anti-Flag (Sigma-Aldrich). After a secondary conjugation with Alexa Fluor
antibodies for 90min (anti-mouse Alexa 488 and anti-rabbit Alexa 568), the
coverslips were mounted in Prolong Gold Antifade reagent (with DAPI; P-36931
Invitrogen). Coverslips were examined with a confocal microscope (63 NA 1.4
Plan Apochromat oil immersion lens; LSM780). Eight to ten random ﬁelds of 6–10
cells each were imaged per condition. The signal intensities were quantiﬁed using
ImageJ. The acquisition settings were identical among all the conditions examined.
Quantiﬁcation of colocalization. For quantifying the colocalization of different
proteins, at least 10 ﬁelds of 3–5 cells per ﬁeld were taken for each sample
per experiment. Each experiment was performed at least twice while the
exposure settings were unchanged during acquisition of various samples.
Images were examined with Volocity software and Pearson’s coefﬁcients were
used for quantifying the colocalization. Statistical analysis was performed using
Student’s t-test.
Quantiﬁcation of cell toxicity and polyQ aggregation. EGFP-HTT(Q74),
N17-103Q-GFP, N17-97QP-GFP and GFP-ATXN3(Q84) aggregation were
monitored with a ﬂuorescence microscope. The counting method has been
previously described35. When using EGFP-HTT(Q74), at least 250 cells were
counted per coverslip and the proportion of cells with at least one aggregate was
scored as a percentage of the total number of transfected cells. The apoptotic cell
death was assessed by measuring the percentage of nuclei with morphological
changes (fragmented or condensed nuclei). The experiments were performed
without knowing the identity of the slides at least three times in triplicates.
For analysing the N17-103Q-GFP, N17-97QP-GFP aggregation, at least 300
cells were counted per coverslip and the proportion of cells with at least one
aggregate was scored as a percentage of the total number of transfected cells. For
analysing the GFP-ATXN3(Q84) aggregation at least 400 cells were counted per
coverslip.
Cell lysis and western blot analysis. Cells were washed twice in cold PBS and
lysed in RIPA buffer (150 nM NaCl, 1% NP40, 0.5% NaDoc, 0.1% SDS, 50mM
Tris, from Sigma-Aldrich) and a protease inhibitors mix from Roche Diagnostics).
The samples were kept 30min at 4 C to ensure complete lysis and then centrifuged
at 16,200 g for 15min to pellet the insoluble membranes. The protein levels from
supernatant were quantiﬁed using an assay based on the Bradford method, the
BioRad Protein Assay Kit II (BioRad) and normalized for loading. Cell lysates were
further diluted in 2 Laemmli Sample Buffer (161-0737 BioRad), boiled for
7–10min at 100 C and subjected to an SDS–PAGE separation, followed by
transfer on PDVF membranes using the BioRad mini gel system. The membranes
were blocked in 6% milk in 0.1% Tween in PBS for 1 h and incubated with primary
antibody at 4 C overnight. Incubation with secondary antibody for 90min was
followed by protein visualization either with the ECL detection kit (GE Healthcare)
or directly on a LICOR machine. Proteins levels were quantiﬁed using ImageJ
software.
Co-immunoprecipitation (dimerization) assay. This assay was previously
described34,62. ATG16L1þ and ATG16L1 HeLa cells were exposed to two
rounds of control or CCT5 siRNAs and seeded in 6-well plates. For Flag
immunoprecipitation, cells were transfected with 1.5mg of GFP-tagged-HTT(1–548)
and 1 mg of Flag-tagged-HTT(1–588) combined with 5 ml of TransIT-2020 (Mirus)
for 24 h, and lysed in Buffer A, containing 20mM Tris pH 7.4, 150mM NaCl,
2mM MgCl2, 0.5% NP40, protease inhibitors mix and phosphatase inhibitors from
Roche Diagnostics. For GFP immunoprecipitation, cells were transfected with 1 mg
of GFP-tagged-HTT(1–548) and 1.5 mg of Flag-tagged-HTT(1–588) combined with
5 ml of TransIT-2020 (Mirus) for 24 h, and lysed in Buffer B, containing 10mM
Tris pH 7.4, 150mM NaCl, 1mM EDTA pH8, 1% Triton, protease inhibitors mix
and phosphatase inhibitors from Roche Diagnostics. Six hundred micrograms
total protein per condition were incubated with primary either anti-Flag M2
(Sigma-Aldrich) or anti-GFP (rabbit polyclonal Clonotech) at 4 C overnight.
The immune-complexes were cleared with magnetic Protein G Beads (Invitrogen).
Input lysates were run simultaneously with the IP samples on 10% polyacrylamide
gels and visualized with LICOR.
GFP-Trap method. GFP-Trap immunoprecipitations were performed using the
GFP-Trap_MA beads (Chromotek gtma-20) following the manufacturer’s
instructions.
Lysosomal pH and Cathepsin L activity. One day before live cell imaging, HeLa
cells were seeded in 35mm petri dishes with 14mm microwells (P35G-1.0-14-C
MatTek). LysoSensor Yellow/Blue DND-160 (L-7545 Molecular Probes) probe was
added at 1.5 mM in full medium for 20min, removed, then the cells washed twice
and visualized at a confocal microscope. Primary cortical neurons were seeded in
the MatTek live-cell dishes, treated with shRNA lentiviral particles (standard
protocol: 20ml of the 100 viruses stock on day 4, media changed in the following
day and cultured for another 5–6 days) and probed for LysoSensor Yellow/Blue at
1.5 mM in full medium for 5–10min. The ﬂuorescence intensities in the blue and
yellow channels were quantiﬁed in ImageJ.
The lysosomal protease activity was measured using the Cathepsin L Activity
Kit (65306 Abcam) following the manufacturer’s instructions.
Proteasome activity. HeLa cells were seeded in 6-well plates and the assay was
performed in triplicates. First, the cells were washed twice with PBS, then collected
in 1.5ml Eppendorf tubes and centrifuged at 2,000 r.p.m. for 5min at 4 C. The
cellular pellet was resuspended in 100 ml 50mM Tris, pH 7.4, I mM DTT and
sonicated twice for 10 s. The cellular debris was removed by centrifugation
(13,000 r.p.m., 10min, 4 C), then the supernatant was collected in a separate tube.
For measuring the chymotrypsin-like activity of the proteasome, 25 mg proteins
were used per reaction together with 100 mM of Suc-LLVY-ACM (Enzo,
BML-P802-0005). The activity was measured for 1 h at 37 C at 5min interval
using a plate reader with Ex. 380 nm and Em. 460 nm.
EGFR degradation assay. HeLa cells were serum starved (DMEM with 0.2% fetal
bovine serum) for 4 h before loading with the receptor ligand EGF (100 ngml 1)
in the presence of cyclohexamide (CHX, 40 mgml 1) for 30min. After, the cells
were washed twice with PBS, and further incubated in serum-free media in the
presence of cyclohexamide for another 1 or 2 h. At ‘time 0’ the cells were lysed
immediately after the PBS wash. For each individual time point we normalized the
data to ‘time 0’ (EGFþ ; CHXþ ) and used two-tailed t-test to assess the protein
level differences between Ctrl- and CCT5-depleted cells. Two ways ANOVA was
performed to assess the overall signiﬁcance of EGFR degradation between the
control and CCT5 knockdown cells.
Drosophila stocks and genetics. To check the effect of Cct subunits
downregulation on the autophagy substrate Ref(2)P/p62, ﬂies of the
genotype w; Cg-GAL4 UAS-GFP-Ref(2)P71 were crossed to UAS-RNAi lines for
Cct5 (Cct5K108095(v109505), labelled Cct5KK, or Cct5NIG.8439R, labelled Cct5NIG - the
sequences of these RNAi lines do not overlap) or Cct7 (Cct7KK101540(v108585),
labelled Cct7KK ) or to the appropriate background control (w1118, VDRC stock
60100). For assessing whether the phenotype due to Cct5 and Cct7 downregulation
was autophagy dependent, virgins of genotypes Atg8aKG07569 (ref. 72),
Atg8aKG07569; Cct5KKor Atg8aKG07569; Cct7KKwere crossed with males of genotype
w;Cg-GAL4 UAS-GFP-Ref(2)P, and Atg8aKG07569/Y crawling third-instar larvae
were selected for western blot or immunoﬂuorescence. Otherwise virgins
expressing w;Cg-GAL4 UAS-mCherry-Atg8a (ref. 73) were crossed with either
Cct5KK or w1118males. For western blots, the fat bodies of three larvae per genotype
were dissected and lysed in Laemmli buffer. The following antibodies were used:
rabbit polyclonal antibody anti-Ref(2)P (1:5,000 WB74), rabbit polyclonal antibody
anti-Atg8a (1:5,000 WB74); mouse monoclonal anti-CCT5 (1:500 WB,
WH0022948M1 Sigma-Aldrich), rabbit polyclonal anti-CCT7 (1:500 WB,
HPA008425 Sigma-Aldrich) and rabbit polyclonal anti-actin (1:2,000 WB, A2066
Sigma-Aldrich). For immunoﬂuorescence analysis, the fat bodies of 5 larvae per
genotype were ﬁxed in 4% formaldehyde for 30min at room temperature (Sigma)
and the DNA stained with TO-PRO-3 (1:1,500; Life Technologies). Pictures of the
whole larvae were taken using a Leica MZ16F microscope connected to a Leica
DFC340FX digital camera. The macroscopic images showing GFP-Ref2(P)
aggregates in Extended Data Fig. 11e were taken with either a 2 objective (whole
larvae images) or an 8 objective (enlarged images). Quantiﬁcation of western
blot bands or Atg8a vesicles (number, area and size per cell) was performed using
ImageJ and the statistical analysis done as described above.
Statistical analysis. Densitometry of western blot bands was performed using
ImageJ. Each image was set to 8 bits format, inverted and the background was
subtracted before measuring the band intensity in ImageJ. The graphs show the
mean from either independent experiments or one representative experiment in
triplicates. For each graph we speciﬁed whether the error bars are standard
deviations (s.d.) or s.e. of the mean (s.e.m.). The P values for the densitometry were
either determined with one sample t-test in Origin v8.1, where the control was
initially set up to 100% (when the data from multiple experiments were combined)
or two-tailed/one-tailed Student’s t-test in Excel software, otherwise. For the polyQ
aggregation representative experiments performed in triplicates, the P value was
determined using the two-tailed t-test and the error bars represent the s.d. When
multiple polyQ experiments were pulled together, the P value was determined
using the one sample t-test and the error bars represent the s.e.m. For statistical
comparisons we considered similar variance between the groups being compared.
For colocalization experiments, we used Volocity software to determine the
Pearson’s coefﬁcients and two-tailed t-test to compute the P value within one
representative experiment. All experiments were performed at least twice, unless
otherwise speciﬁed.
Data availability. Authors can conﬁrm that all relevant data are included in the
paper and/or its supplementary Information ﬁles.
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